What Happened?
Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the company reported strong fourth-quarter results that exceeded expectations, with same-store sales significantly surpassing analysts' forecasts and EPS outperforming Wall Street's estimates by a wide margin. Growth was powered by strong performance in the Pharmacy & Consumer Wellness segment. On the other hand, its full-year EPS guidance missed. Despite this, we think this was a decent quarter.
Is now the time to buy CVS Health? Access our full analysis report here, it’s free.
What The Market Is Telling Us
CVS Health’s shares are somewhat volatile and have had 11 moves greater than 5% over the last year. But moves this big are rare even for CVS Health and indicate this news significantly impacted the market’s perception of the business.
CVS Health is up 44.5% since the beginning of the year, but at $63.90 per share, it is still trading 19.9% below its 52-week high of $79.76 from March 2024. Investors who bought $1,000 worth of CVS Health’s shares 5 years ago would now be looking at an investment worth $866.31.
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
